Acute exacerbations of underlying COPD are a common cause of respirato
ry deterioration. Developments have been made in preventive measures,
but admission to hospital for acute exacerbations can be expected to r
emain common. Several expert consensus guidelines have been published
to define the appropriate management of COPD patients. These consensus
guidelines generally agree, but all acknowledge a lack of large well-
controlled clinical studies, especially studies focusing on the manage
ment of acute exacerbations. Consequently, many potential controversie
s exist about the details of managing patients with acute exacerbation
s. Although studies of many fundamental aspects of management are stil
l needed, the results of controlled clinical trials are sufficient to
emphasise the importance of a careful clinical assessment, supplementa
l oxygen, inhaled bronchodilators to partially improve airway obstruct
ion, corticosteroids to decrease the likelihood of treatment failures
and to speed recovery, antibiotics, especially in severe patients, and
non-invasive positive-pressure ventilation for treatment of acute ven
tilatory failure in selected patients.